Citations

Clear

4610 citation(s) found for "Lu, Brian".

Contemporary Trends in Nephrectomy for Renal Cell Carcinoma in the United States: Results From a Population Based Cohort
Kim, Simon P. , Shah, Nilay D. , Weight, Christopher , Thompson, R. Houston, Moriarty, James P. , Shippee, Nathan D. , Costello, Brian A. , Boorjian, Stephen A. , Leibovich, Bradley C. , Shippee, Nathan

Mayo Clinic

Journal of Urology | September 26, 2011 | Volume: 186 | Issue: 5 | Pages: 1779-1785

10.1016/j.juro.2011.07.041 | PMID 21944105 Get It

Detection of Asymptomatic Recurrence During Routine Oncological Followup After Radical Cystectomy is Associated With Improved Patient Survival
Boorjian, Stephen A. , Tollefson, Matthew K. , Cheville, John C. , Costello, Brian A. , Thapa, Prabin , Frank, Igor

Mayo Clinic

Journal of Urology | September 26, 2011 | Volume: 186 | Issue: 5 | Pages: 1796-1802

10.1016/j.juro.2011.07.005 | PMID 21944088 Get It

Ano1 as a regulator of proliferation
Stanich, Jennifer E., Gibbons, Simon J. , Eisenman, Seth T., Bardsley, Michael R., Rock, Jason R. , Harfe, Brian D. , Ördög, Tamás , Farrugia, Gianrico , Gibbons, S J

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | September 23, 2011 | Volume: 301 | Issue: 6 | Pages: G1044-G1051

10.1152/ajpgi.00196.2011 | PMID 21940901 Get It

Ano1 is a recently discovered Ca2+-activated Cl− channel expressed on interstitial cells of Cajal (ICC) that has been implicated in slow-wave activity in the gut. However, Ano1 is expressed on all classes of ICC, even those that do not contribute to generation of the slow wave, suggesting that Ano1 may have an alternate function in these cells. Ano1 is also highly expressed in gastrointestinal stromal tumors. Mice lacking Ano1 had fewer proliferating ICC in whole mount preparations and in culture, raising the possibility that Ano1 is involved in proliferation. Cl− channel blockers decreased proliferation in cells expressing Ano1, including primary cultures of ICC and in the pancreatic cancer-derived cell line, CFPAC-1. Cl− channel blockers had a reduced effect on Ano1(−/−) cultures, confirming that the blockers are acting on Ano1. Ki67 immunoreactivity, 5-ethynyl-2′-deoxyuridine incorporation, and cell-cycle analysis of cells grown in low-Cl− media showed fewer proliferating cells than in cultures grown in regular medium. We confirmed that mice lacking Ano1 had less phosphorylated retinoblastoma protein compared with controls. These data led us to conclude that Ano1 regulates proliferation at the G1/S transition of the cell cycle and may play a role in tumorigenesis.
Statistical Parametric Mapping Demonstrates Asymmetric Uptake with Tc-99m ECD and Tc-99m HMPAO SPECT in Normal Brain
Brinkmann, Benjamin H. , Stead, Matt, Kazemi, Noojan , O’Brien, Terence J. , So, Elson L., Blumenfeld, Hal , Mullan, Brian P., Jones, David T. , Worrell, Gregory A. , Brinkmann, Benjamin H

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | September 21, 2011 | Volume: 32 | Issue: 1 | Pages: 190-198

10.1038/jcbfm.2011.123 | PMID 21934696 Get It

Tc-99m ethyl cysteinate diethylester (ECD) and Tc-99m hexamethyl propylene amine oxime (HMPAO) are commonly used for single-photon emission computed tomography (SPECT) studies of a variety of neurologic disorders. Although these tracers have been very helpful in diagnosing and guiding treatment of neurologic disease, data describing the distribution and laterality of these tracers in normal resting brain are limited. Advances in quantitative functional imaging have demonstrated the value of using resting studies from control populations as a baseline to account for physiologic fluctuations in cerebral perfusion. Here, we report results from 30 resting Tc-99m ECD SPECT scans and 14 resting Tc-99m HMPAO scans of normal volunteers with no history of neurologic disease. Scans were analyzed with regions of interest and with statistical parametric mapping, with comparisons performed laterally (left vs. right), as well as for age, gender, and handedness. The results show regions of significant asymmetry in the normal controls affecting widespread areas in the cerebral hemispheres, but most marked in superior parietotemporal region and frontal lobes. The results have important implications for the use of normal control SPECT images in the evaluation of patients with neurologic disease.
Optimization of PSA Screening Policies
Balasubramanian, Hari , Shah, Nilay D., Inman, Brant A. , Zhang, Jingyu , Denton, Brian T. , Inman, Brant A

Mayo Clinic

Medical Decision Making | September 20, 2011 | Volume: 32 | Issue: 2 | Pages: 337-349

10.1177/0272989x11416513 | PMID 21933990 Get It

Objective. To estimate the benefit of PSA-based screening for prostate cancer from the patient and societal perspectives. Method. A partially observable Markov decision process model was used to optimize PSA screening decisions. Age-specific prostate cancer incidence rates and the mortality rates from prostate cancer and competing causes were considered. The model trades off the potential benefit of early detection with the cost of screening and loss of patient quality of life due to screening and treatment. PSA testing and biopsy decisions are made based on the patient’s probability of having prostate cancer. Probabilities are inferred based on the patient’s complete PSA history using Bayesian updating. Data Sources. The results of all PSA tests and biopsies done in Olmsted County, Minnesota, from 1993 to 2005 (11,872 men and 50,589 PSA test results). Outcome Measures. Patients’ perspective: to maximize expected quality-adjusted life years (QALYs); societal perspective: to maximize the expected monetary value based on societal willingness to pay for QALYs and the cost of PSA testing, prostate biopsies, and treatment. Results. From the patient perspective, the optimal policy recommends stopping PSA testing and biopsy at age 76. From the societal perspective, the stopping age is 71. The expected incremental benefit of optimal screening over the traditional guideline of annual PSA screening with threshold 4.0 ng/mL for biopsy is estimated to be 0.165 QALYs per person from the patient perspective and 0.161 QALYs per person from the societal perspective. PSA screening based on traditional guidelines is found to be worse than no screening at all. Conclusions. PSA testing done with traditional guidelines underperforms and therefore underestimates the potential benefit of screening. Optimal screening guidelines differ significantly depending on the perspective of the decision maker.
Atrial Tachycardia Originating From a Donor Pulmonary Vein in a Lung Transplant Recipient
Nazmul, Mohammed, Munger, Thomas M. , Powell, Brian D.

Mayo Clinic

Circulation | September 12, 2011 | Volume: 124 | Issue: 11 | Pages: 1288-1289

10.1161/circulationaha.111.029413 | PMID 21911797 Get It

Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells
Olin, Michael R. , Andersen, Brian M. , Litterman, Adam J. , Grogan, Patrick T., Sarver, Aaron L. , Robertson, Paul T., Liang, Xueqing , Parney, Ian F. , Hunt, Matthew A. , Ohlfest, John R., Chen, Wei , Blazar, Bruce R. , Parney, Ian F

Mayo Clinic

Cancer Research | September 10, 2011 | Volume: 71 | Issue: 21 | Pages: 6583-6589

10.1158/0008-5472.can-11-1166 | PMID 21908554 Get It

Abstract With recent approval of the first dendritic cell (DC) vaccine for patient use, many other DC vaccine approaches are now being tested in clinical trials. Many of these DC vaccines employ tumor cell lysates (TL) generated from cells cultured in atmospheric oxygen (∼20% O2) that greatly exceeds levels found in tumors in situ. In this study, we tested the hypothesis that TLs generated from tumor cells cultured under physiologic oxygen (∼5% O2) would be more effective as a source for DC antigens. Gene expression patterns in primary glioma cultures established at 5% O2 more closely paralleled patient tumors in situ and known immunogenic antigens were more highly expressed. DCs treated with TLs generated from primary tumor cells maintained in 5% O2 took up and presented antigens to CD8 T cells more efficiently. Moreover, CD8 T cells primed in this manner exhibited superior tumoricidal activity against target cells cultured in either atmospheric 20% O2 or physiologic 5% O2. Together, these results establish a simple method to greatly improve the effectiveness of DC vaccines in stimulating the production of tumoricidal T cells, with broad implications for many of the DC-based cancer vaccines being developed for clinical application. Cancer Res; 71(21); 6583–9. ©2011 AACR.
Genetic analysis of aquaporin-4 in neuromyelitis optica
Matiello, Marcelo , Schaefer-Klein, Janet, Hebrink, David D., Kingsbury, D., Atkinson, Elizabeth J. , Weinshenker, Brian G. , Weinshenker, Brian G

Mayo Clinic

Neurology | September 8, 2011 | Volume: 77 | Issue: 12 | Pages: 1149-1155

10.1212/wnl.0b013e31822f045b | PMID 21900637 Get It

Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study
Heit, John A. , Lahr, Brian D. , Petterson, Tanya M. , Bailey, Kent R. , Ashrani, Aneel A. , Melton, L. Joseph

Mayo Clinic

Blood | September 4, 2011 | Volume: 118 | Issue: 18 | Pages: 4992-4999

10.1182/blood-2011-05-357343 | PMID 21890644 Get It

Abstract To test recommended anticoagulation measures as predictors of 180-day venous thromboembolism (VTE) recurrence, we identified all Olmsted County, MN residents with incident VTE over the 14-year period of 1984-1997, and followed each case (N = 1166) forward in time for VTE recurrence. We tested the activated partial thromboplastin time (APTT), international normalized ratio (INR), and other measures of heparin and warfarin anticoagulation as predictors of VTE recurrence while controlling for baseline and time-dependent characteristics using Cox proportional hazards modeling. Overall, 1026 (88%) and 989 (85%) patients received heparin and warfarin, respectively, and 85 (8%) developed VTE recurrence. In multivariable analyses, increasing proportions of time on heparin with an APTT ≥ 0.2 anti-Xa U/mL and on warfarin with an INR ≥ 2.0 were associated with significant reductions in VTE recurrence, while the hazard with active cancer was significantly increased. Time from VTE onset to heparin start, duration of overlapping heparin and warfarin, and inferior vena cava (IVC) filter placement were not independent predictors of recurrence. At a heparin dose ≥ 30 000 U/d, the median proportion of time with an APTT ≥ 0.2 anti-Xa U/mL was 92%, suggesting that routine APTT monitoring and heparin dose adjustment may be unnecessary. In summary, lower-intensity heparin and standard-intensity warfarin anticoagulation are effective in preventing VTE recurrence.
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Tanas, Munir R. , Oliveira, André M. , Erickson‐Johnson, Michele R., Hespelt, Jessica, Hanwright, Philip J. , Flanagan, John J., Fenwick, Kerry, Natrajan, Rachael , Mitsopoulos, Costas , Zvelebil, Marketa , Hoch, Benjamin , Sciot, Raf , West, Robert B. , Lazar, Alexander J. , Ashworth, Alan , Lord, Christopher J. , Rubin, Mark A. , Sboner, Andrea , Luo, Yuling , Weiss, Sharon Whelan , Dêbiec‐Rychter, Maria , Reis‐Filho, Jorge S. , Gerstein, Mark , Rubin, Brian P. , Lazar, Alexander J , Sciot, Raf , Rubin, Mark A

Mayo Clinic

Science Translational Medicine | September 1, 2011 | Volume: 3 | Issue: 98 | Pages: No page available

10.1126/scitranslmed.3002409 | PMID 21885404 Get It

A newly identified gene fusion defines the vascular cancer epithelioid hemangioendothelioma and encodes a chimeric transcription factor.